Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_provenance.
- NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_assertion description "[The case of the anaplastic lymphoma kinase (ALK) nicely exemplifies this, and cell line profiling has revealed that ALK mutations present in a subset of anaplastic large cell lymphomas (ALCLs), non-small cell lung cancers (NSCLCs), and neuroblastomas appear to sensitize cancer cells to treatment with selective ALK kinase inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_provenance.
- NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_assertion evidence source_evidence_literature NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_provenance.
- NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_assertion SIO_000772 19393834 NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_provenance.
- NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_assertion wasDerivedFrom befree-2016 NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_provenance.
- NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_assertion wasGeneratedBy ECO_0000203 NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_provenance.
- befree-2016 importedOn "2016-02-19" NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_provenance.